Sima Jeha
About
Sima Jeha is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology.
According to data from OpenAlex, Sima Jeha has authored 221 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Public Health, Environmental and Occupational Health, 109 papers in Pediatrics, Perinatology and Child Health and 72 papers in Hematology. Recurrent topics in Sima Jeha's work include Acute Lymphoblastic Leukemia research (136 papers), Childhood Cancer Survivors' Quality of Life (89 papers) and Acute Myeloid Leukemia Research (42 papers). Sima Jeha is often cited by papers focused on Acute Lymphoblastic Leukemia research (136 papers), Childhood Cancer Survivors' Quality of Life (89 papers) and Acute Myeloid Leukemia Research (42 papers). Sima Jeha collaborates with scholars based in United States, Lebanon and Singapore. Sima Jeha's co-authors include Ching‐Hon Pui, Hagop M. Kantarjian, Stefan Faderl, Alan Lichtin, Larry I. Lipshultz, Leslie R. Schover, Mary V. Relling, Jörge E. Cortes, Susan O’Brien and Jeffrey E. Rubnitz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Sima Jeha
213 papers receiving 9.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sima Jeha United States | 51 | 4.8k | 3.4k | 3.1k | 2.2k | 1.5k | 221 | 9.1k | ||
| John T. Sandlund United States | 60 | 5.8k 1.2× | 3.4k 1.0× | 4.0k 1.3× | 2.3k 1.0× | 1.7k 1.1× | 169 | 10.5k | ||
| Henrik Hasle Denmark | 53 | 3.0k 0.6× | 4.3k 1.3× | 1.8k 0.6× | 1.4k 0.6× | 3.1k 2.0× | 311 | 9.1k | ||
| Naomi Winick United States | 49 | 6.3k 1.3× | 3.4k 1.0× | 4.4k 1.4× | 2.2k 1.0× | 1.4k 1.0× | 238 | 9.6k | ||
| Gaston K. Rivera United States | 53 | 6.9k 1.4× | 4.6k 1.3× | 3.9k 1.3× | 2.1k 0.9× | 2.2k 1.5× | 166 | 11.2k | ||
| Giuseppe Masera Italy | 45 | 3.9k 0.8× | 3.0k 0.9× | 3.1k 1.0× | 844 0.4× | 1.0k 0.7× | 239 | 7.2k | ||
| Smita Bhatia United States | 43 | 2.7k 0.6× | 809 0.2× | 3.2k 1.0× | 2.2k 1.0× | 1.3k 0.8× | 359 | 8.4k | ||
| Beverly J. Lange United States | 64 | 4.6k 1.0× | 5.0k 1.5× | 2.6k 0.8× | 2.1k 0.9× | 3.4k 2.2× | 213 | 11.5k | ||
| Meenakshi Devidas United States | 59 | 8.0k 1.7× | 4.5k 1.3× | 5.5k 1.7× | 2.8k 1.3× | 1.8k 1.2× | 311 | 12.6k | ||
| Bruce M. Camitta United States | 60 | 6.9k 1.4× | 6.8k 2.0× | 4.2k 1.3× | 2.4k 1.1× | 1.8k 1.2× | 215 | 12.5k | ||
| W. Archie Bleyer United States | 41 | 2.6k 0.5× | 916 0.3× | 2.6k 0.8× | 1.2k 0.5× | 507 0.3× | 93 | 5.5k |
Countries citing papers authored by Sima Jeha
Since
Specialization
Citations
This map shows the geographic impact of Sima Jeha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sima Jeha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sima Jeha more than expected).
Fields of papers citing papers by Sima Jeha
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sima Jeha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sima Jeha. The network helps show where Sima Jeha may publish in the future.
Co-authorship network of co-authors of Sima Jeha
This figure shows the co-authorship network connecting the top 25 collaborators of Sima Jeha. A scholar is included among the top collaborators of Sima Jeha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sima Jeha. Sima Jeha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Graetz, Dylan E., Inam Chitsike, Nickhill Bhakta, et al.. (2024). Stigma in Pediatric Cancer: An Exploratory Study of Osteosarcoma and Retinoblastoma in Guatemala, Jordan, and Zimbabwe. JCO Global Oncology. 10(10). e2400017–e2400017.
2.
Yang, Wenjian, Keito Hoshitsuki, Mary V. Relling, et al.. (2024). Clinical Actionability of the NUDT15 *4 (p.R139H ) Allele and Its Association With Hispanic Ethnicity. Clinical Pharmacology & Therapeutics. 117(3). 724–731.
3.
Hu, Zhongbo, et al.. (2024). Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing. Cancer Medicine. 13(21). e70351–e70351.
4.
Graetz, Dylan E., Alia Ahmad, Carlos Rodríguez‐Galindo, et al.. (2024). Functions of patient- and family-centered pediatric cancer communication in Pakistan. Frontiers in Oncology. 14. 1393908–1393908.
5.
Hoshitsuki, Keito, Yinmei Zhou, John Choi, et al.. (2023). Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia. Leukemia. 37(9). 1782–1791.
6.
Graetz, Dylan E., Alia Ahmad, Carlos Rodríguez‐Galindo, et al.. (2023). Barriers and Facilitators of Quality Family-Centered Communication in Pakistan. JCO Global Oncology. 9(9). e2300178–e2300178.
7.
Thomsen, Birthe Lykke, Bodil Als‐Nielsen, Rachel Conyers, et al.. (2023). Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment. Frontiers in Pediatrics. 11. 1155449–1155449.
8.
Barnett, Kelly R., Kashi Raj Bhattarai, Baranda S. Hansen, et al.. (2023). Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. Blood Advances. 7(15). 4107–4111.
9.
Lee, Shawn H. R., Wenjian Yang, Kathryn G. Roberts, et al.. (2023). Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL. Journal of Clinical Oncology. 41(35). 5422–5432.
10.
Rihani, Rawad, et al.. (2023). The burden and scope of childhood cancer in displaced patients in Jordan: The King Hussein Cancer Center and Foundation Experience. Frontiers in Oncology. 13.
11.
Khan, Muhammad Saghir, Mazin Faisal Al‐Jadiry, Nidale Tarek, et al.. (2021). Pediatric oncology infrastructure and workforce training needs: A report from the Pediatric Oncology East and Mediterranean (POEM) Group. Pediatric Blood & Cancer. 68(9). e29190–e29190.
12.
Zhou, Yinmei, John C. Panetta, Emily Browne, et al.. (2017). The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia. Blood Cancer Journal. 7(2). e531–e531.
13.
Pauley, Jennifer L., John C. Panetta, Deqing Pei, et al.. (2016). Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate. Journal of Pediatric Hematology/Oncology. 38(6). 449–452.
14.
Bhojwani, Deepa, Noah D. Sabin, Deqing Pei, et al.. (2014). Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 32(9). 949–959.
15.
Roberts, Kathryn G., Deqing Pei, Dario Campana, et al.. (2014). Outcomes of Children With BCR-ABL1 –Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease. Journal of Clinical Oncology. 32(27). 3012–3020.
16.
Bhojwani, Deepa, Rashid Darbandi, Deqing Pei, et al.. (2014). Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. European Journal of Cancer. 50(15). 2685–2694.
17.
Leung, Wing, Ching‐Hon Pui, Elaine Coustan‐Smith, et al.. (2012). Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood. 120(2). 468–472.
18.
Hijiya, Nobuko, Blythe Thomson, Michael S. Isakoff, et al.. (2011). Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Blood. 118(23). 6043–6049.
19.
Hijiya, Nobuko, John C. Panetta, Yinmei Zhou, et al.. (2006). Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood. 108(13). 3997–4002.
20.
Jeha, Sima, Paul S. Gaynon, Bassem I. Razzouk, et al.. (2006). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 24(12). 1917–1923.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by John T. Sandlund Breakdown of academic impact, for papers by Henrik Hasle Breakdown of academic impact, for papers by Naomi Winick Breakdown of academic impact, for papers by Gaston K. Rivera Breakdown of academic impact, for papers by Giuseppe Masera Breakdown of academic impact, for papers by Smita Bhatia Breakdown of academic impact, for papers by Beverly J. Lange Breakdown of academic impact, for papers by Meenakshi Devidas Breakdown of academic impact, for papers by Bruce M. Camitta Breakdown of academic impact, for papers by W. Archie Bleyer